Cite
CK2—An Emerging Target for Neurological and Psychiatric Disorders
MLA
Julia Castello, et al. “CK2—An Emerging Target for Neurological and Psychiatric Disorders.” Pharmaceuticals, vol. 10, no. 1, Jan. 2017, p. 7. EBSCOhost, https://doi.org/10.3390/ph10010007.
APA
Julia Castello, Andre Ragnauth, Eitan Friedman, & Heike Rebholz. (2017). CK2—An Emerging Target for Neurological and Psychiatric Disorders. Pharmaceuticals, 10(1), 7. https://doi.org/10.3390/ph10010007
Chicago
Julia Castello, Andre Ragnauth, Eitan Friedman, and Heike Rebholz. 2017. “CK2—An Emerging Target for Neurological and Psychiatric Disorders.” Pharmaceuticals 10 (1): 7. doi:10.3390/ph10010007.